Tailor-Made Pentablock Copolymer Based Formulation for Sustained Ocular Delivery of Protein Therapeutics

Figure 13

In vitro release of FITC-BSA and IgG from PB-B NPs. Results are described in mean ± SD, 𝑛=3.